Harvard Bioscience (HBIO) Tops Q1 EPS by 2c

Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $30 million versus the consensus estimate of $28.95 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• VerticalScope invests $6.1M in Canadian AI firm AltaML
• Berenberg Downgrades Siemens Healthineers (SHL:GR) (SEMHF) to Hold